Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
- PMID: 25700378
- PMCID: PMC4391659
- DOI: 10.1183/09031936.00216814
Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
Abstract
LTBI treatment: a systematic review on the best clinical approach to monitor the adverse events of preventive therapy
Conflict of interest statement
Conflict of interest: Disclosures can be found alongside the online version of this article at
References
-
- Mack U, Migliori GB, Sester M, et al. . LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956–973. - PubMed
-
- Dye C, Scheele S, Dolin P, et al. . Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 1999; 282: 677–686. - PubMed
-
- Comstock GW, Livesay VT, et al. . The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99: 131–138. - PubMed
-
- Leung CC, Rieder HL, Lange C, et al. . Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J 2011; 37: 690–711. - PubMed
-
- Steele MA, Burk RF, DesPrez RM. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest 1991; 99: 465–471. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical